EMBL Seminars

Join industry recruiters and hiring managers from Germany, Poland, and the UK as they share practical advice on preparing for successful non-academic interviews, followed by an interactive Q&A session. Learn the dos and don'ts of industry interviews, the types of questions recruiters are likely to ask, and how to make a strong impression throughout the interview process.

Please register for this zoom webinar: https://embl-org.zoom.us/webinar/register/WN_HJ0jEEc2RRKv3QzEN1F0vA

Please note that the talk will be recorded.
*For the FAQ section, as a zoom participant, please use either the chat function (the host will read out your question).

Abstract

Epigenetic components regulate many biological phenomena during development and normal physiology. When dysregulated, epigenetic components can also accompany or drive diseases. One main class of epigenetic components are Polycomb group proteins. Originally, Polycomb proteins were shown to silence gene expression. We found that this function involves the regulation of 3D chromosome folding and we found that Polycomb components can induce the formation of long-distance interactions or chromatin loops that may play instructive roles in gene regulation as well as serve as scaffolding elements that contribute to enhancer-promoter specificity. Perturbation of Polycomb components is involved in human cancer and leads to tumorigenesis in flies. Surprisingly, even upon a transient depletion followed by restoration of the full Polycomb compendium, epithelial cells lose their normal differentiated fate, continue proliferating and establish aggressive tumors, demonstrating that cancer can have a fully epigenetic origin. Similarly, transient perturbation of histone acetylation in mouse ES cells and gastruloids shows that they can record chromatin changes and that this results in cellular memory of the perturbation states. The implication of these data will be discussed.

Abstract
 

Most virus–host battles have been won or lost without leaving an evolutionary trace. Endogenous retroviruses (ERVs) are a fascinating exception: they originate when an exogenous retrovirus infects the germline and becomes integrated into the host genome, leaving behind a molecular record of past viral invasions. Although the ERV repertoire of a host genome provides a snapshot of these historical events, it reveals little about how a retrovirus becomes established in a new host, or how the host recognizes and silences the invader.
In this seminar, I will present the biology of an invading ERV in Drosophila melanogaster, examining the molecular and cell-biological basis of its replication and the host defenses that counter it. This system offers an opportunity to investigate how a viral infection becomes an endogenous genomic element, and how host genomes respond to contain it.

Abstract
Fertilization requires gamete recognition and membrane fusion, yet the molecular basis of this process in vertebrates remains unknown. We identify SPARK (sperm protein assembly and receptor-binding key), a conserved multi-protein complex that integrates all known sperm fertilization factors, including TMEM81–IZUMO1–SPACA6 and DCST1/2, together with two newly identified components, TMDD1 and FAM187A. SPARK subunits are mutually dependent for stability in mature sperm, and disruption of any single component causes male sterility in zebrafish and mice. Incubating zebrafish sperm with soluble egg receptor Bouncer partially rescues fertilization of Bouncer-deficient eggs in a SPARK-dependent manner, consistent with egg receptor binding priming the complex for fusion. Thus, we propose SPARK as a con-served molecular machine that couples gamete recognition to membrane fusion. 

Connection details
Zoom*: [https://www.google.com/url?q=https://embl-org.zoom.us/j/96371601172?pwd%3DmP2XcTZcUUXnvnzTT675RKig8WaVMx.1%26jst%3D2&sa=D&source=calendar&ust=1788603892678661&usg=AOvVaw1cyBHmfWFI5SwD3hjt2WbJ] (Meeting ID: [96371601172], Password: [740195])

Please note that the talk will yes/not be recorded.
*For the FAQ section, as a zoom participant, please use either the chat function (the host will read out your question) or the “raise your hand” function and turn on your microphone.

Location: Room 301, Building D (3rd floor), Università della Sapienza di Roma - Viale Regina Elena 295

Abstract

To be announced

Abstract

EMBL “Entrepreneurial Minds” is a  quarterly webinar series crafted to ignite entrepreneurial spirit and initiatives among all EMBL staff and fellows. Our speakers share practical insights into entrepreneurship, technology transfer, research commercialisation, and navigating start-up landscapes. Through engaging online webinars, attendees will explore success stories, learn from speaker experiences, and connect with industry experts including entrepreneurs, tech transfer professionals, and EMBL alumni. 

This event is open to all and will be livestreamed from EMBL Rome. Participants from EMBL Rome and other Monterotondo campus institutes are encouraged to attend in-person.

Please note - for our planning, we kindly ask both in-person and online participants to register at: https://embl-org.zoom.us/webinar/register/WN__n6yIi-wR4e0QhhNG8hYzQ 
Please note that the talk will be recorded.

About the speaker
In this seminar we will hear from Ilaria Ferlenghi, Global Scientific Leader and Associate Director at GSK.

Ilaria is an esteemed structural biologist and microscopy leader with over 30 years of expertise in cryo-electron microscopy (cryo-EM), AI/ML applications, and structural analysis, including more than 20 years dedicated to vaccine research and development. She was among the pioneers in introducing cryo-EM in the pharmaceutical industry to identify and characterize new vaccine candidates, contributing significantly to its adoption as a transformative tool in vaccine R&D. In this context, she played a key role in the design and development of the BEXSERO vaccine.

As Global Scientific Leader and Associate Director at GSK, she leads scientific vision and strategic direction across therapeutic areas, driving innovation in structural vaccinology. Ilaria developed the GEMINI AI/ML-based platform, which integrates structural biology with artificial intelligence to accelerate the identification of antigens as potential vaccine candidates.

Her career spans leadership roles at GSK and Novartis, with deep specialization in advanced microscopy techniques and vaccine R&D. She holds a PhD in Structural Biology and Biophysics from the University of Heidelberg, followed by postdoctoral research at HHMI (Boston) and CNRS (France). Widely recognized for fostering impactful collaborations between academia and industry, Ilaria continues to drive scientific innovation at the intersection of structural biology, digital technologies, and global health.

She serves as a member of nine scientific advisory boards worldwide, contributing her expertise to advance innovation and translational science in vaccine development and beyond. She is also the co-founder of the WeInspireBio initiative, a global effort dedicated to inspiring and supporting the next generation of scientists.